Unitaid

We save lives by making new health products available and affordable for people who need them most—fast. Hosted by WHO. www.unitaid.org
(1)

Unitaid was established in 2006 by the governments of Brazil, Chile, France, Norway and the United Kingdom. Today it is backed by a formidable “North-South” membership, including Cyprus, Korea, Luxembourg, Spain and the Bill & Melinda Gates Foundation alongside Cameroon, Congo, Guinea, Madagascar, Mali, Mauritius and Niger. Civil society groups also govern Unitaid, giving a voice to non-government

al organisations and communities living with HIV, malaria and tuberculosis. Based in Geneva and hosted by the World Health Organization, Unitaid has been entrusted by these members to use innovative financing– the world’s first “solidarity contribution” – for innovative impact.

05/06/2026

A new step forward in HIV prevention in South Africa.

Today, the first doses of lenacapavir were rolled out, marking an important milestone in expanding access to a long-acting HIV prevention option given just twice a year.

For many people, this could mean a prevention option that fits more easily into daily life, with fewer clinic visits and less frequent dosing.

South Africa carries one of the highest burdens of HIV globally, making access to new prevention options especially important.

At Unitaid, we are working with partners to help ensure this innovation can reach the people who need it most, supporting implementation, advancing regional manufacturing, and helping pave the way for affordable generic versions expected to cost around $40 per person per year.

Because prevention only works when it reaches the people who need it most.

05/06/2026

Extreme heat can degrade medicines, reduce their potency and compromise care before they reach patients. As temperatures rise, health products are increasingly exposed to conditions beyond their tested limits across supply chains, putting their safety and effectiveness at risk.

These impacts are most severe in low- and middle-income countries, where maintaining controlled storage and transport is often difficult. Strengthening access to climate-resilient, heat-stable products is essential to ensure lifesaving care remains safe, effective and accessible in a changing climate.

Learn more:https://unitaid.org/uploads/12858-Knowledge-Paper-Heat-Proofing-Health-Products-RGB14.pdf

04/06/2026

Lenacapavir is a long-acting HIV prevention option that requires just two injections a year.

It complements existing prevention approaches, including daily oral medication (PrEP), which helps reduce the risk of HIV infection. However, daily prevention is not always easy to maintain. People may face barriers such as stigma, access to clinics, or difficulty taking a daily pill consistently.

A 2025 partnership between Dr. Reddy's Laboratories Ltd., Unitaid the Clinton Health Access Initiative, and Wits RHI is helping translate innovation into access by enabling a pathway to affordable generic lenacapavir at around US$40 per person per year across 120 low- and middle-income countries.

The focus is on making lenacapavir affordable, scalable, and accessible so it can reach more people and support continued progress in reducing new HIV infections.

Find out more below

03/06/2026

Lenacapavir represents a once-in-a-generation HIV prevention opportunity, but only if it reaches those who need it most.

Long-acting HIV prevention innovations could reshape outcomes, particularly for adolescent girls and young women and other populations who bear a disproportionate burden of new infections and face barriers to using daily prevention options.

But innovation does not automatically translate into access.

The decisive factor is whether systems, markets and delivery pathways can reach people at scale.

An innovation only becomes impact when it moves beyond regulatory approval and into real-world use.

02/06/2026

A phone call changed the course of Louis Da Gama’s life.

He was told malaria was resurging. Millions of people were dying. And the world was looking away.

More than 25 years later, Louis has seen what is possible when communities, innovation and political will come together. Malaria deaths have fallen, new tools have saved millions of lives, and global partnerships have helped shift the trajectory of the disease.

But progress is fragile.

Conflict, climate shocks, drug and insecticide resistance, and funding gaps continue to threaten decades of hard-won gains. Without sustained commitment, the world risks losing ground in the fight against malaria.

One lesson remains constant: communities are not passive recipients of aid, they are engines of change. When empowered and resourced, they move mountains.

We have the tools, the science, and the proof that progress is possible.

What is needed now is the resolve to stay the course.

01/06/2026

The Government of Kenya recently announced a US$7.8 million investment to scale up lifesaving maternal health products nationwide.

The decision builds on evidence generated through the AMPLI-PPHI program, where Unitaid and Jhpiego supported the introduction and evaluation of tools to prevent postpartum hemorrhage, a leading cause of maternal death.

This is what it looks like when innovation, data, and country leadership come together to save lives.

Find out more below.

01/06/2026

Health innovation alone does not change lives.

Over the past 20 years, efforts have focused on closing the gap between innovation and access, helping expand availability of more than 150 health innovations across HIV, malaria, maternal health and diagnostics.

Innovation continues to move quickly. The challenge is ensuring it translates into impact at scale, for the people it is intended to reach.

29/05/2026

Over 20 years, we have focused on one persistent challenge in global health: ensuring innovation translates into access at scale.

That work has helped expand access to more than 150 health innovations, reaching 320 million people each year.

Because when access is built into how innovation is delivered, impact scales faster and further.

29/05/2026

Africa CDC is thrilled to invite you to today's session of the Health Partnership Webinar Series.

The discussion will bring together leading experts in research, clinical innovation and programme management to examine how collaboration can accelerate translational research: From Scientific Discovery to Clinical Application.

🗓 Friday, 29 May 2026
⏰ 15:00–16:30 EAT | 14:00–15:30 CET
🔗 Register here: tiny.cc/bu72101

28/05/2026

Margaret Happy lost her two sisters in the 1990s, when HIV treatment was not available.

Today, she works in Uganda to help prevent advanced HIV disease through timely diagnosis and care.

At Unitaid, we are working to strengthen access to CD4 testing alongside viral load testing, ensuring people can be identified and treated in time.

But in some settings, access is declining—putting timely diagnosis at risk.

Read more about why CD4 testing still matters and what’s being done to protect access.

Link below.

Adresse

Global Health Campus, Chemin Du Pommier 40, 5th Floor
Geneva
1218

Öffnungszeiten

Montag

09:00 - 17:00

Webseite

http://www.unitaid.org/

Benachrichtigungen

Lassen Sie sich von uns eine E-Mail senden und seien Sie der erste der Neuigkeiten und Aktionen von Unitaid erfährt. Ihre E-Mail-Adresse wird nicht für andere Zwecke verwendet und Sie können sich jederzeit abmelden.